Placebo BID
Placebo BID is a pharmaceutical drug with 10 clinical trials. Currently 2 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
5
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
2
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis
Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome
Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease
To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Postherpetic Neuralgia
Topical Ibuprofen for Delayed Onset Mulscle Soreness
Clinical Trials (10)
Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis
Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome
Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease
To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Postherpetic Neuralgia
Topical Ibuprofen for Delayed Onset Mulscle Soreness
To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain
Efficacy and Safety of SOM3355 in Huntington's Disease Chorea
Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Seizures Post Intracerebral Hemorrhage
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10